CuZnSOD and MnSOD immunoreactivity in brain stem motor neurons from amyotropic lateral sclerosis patients

Acta Neuropathologica

Volumn 95, Issue 1, 1997, Pages 63-70

  Liu, Yu ^a   Brooks, Benjamin R ^a,b   Taniguchi, Naoyuki ^c   Hartmann, Henrik A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

ALS; Brain stem motor neurons; CuZnSOD; Immunoantibodies; MnSOD

Indexed keywords

ANTIBODY; COPPER ZINC SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE;

ADULT; AGED; AMBIGUUS NUCLEUS; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN STEM; CELL LOSS; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FACIAL NERVE; FEMALE; GLIA CELL; HUMAN; HYPOGLOSSAL NERVE; IMMUNOREACTIVITY; MALE; MOTONEURON; PATIENT; PRIORITY JOURNAL; STAINING; TERMINAL DISEASE; TRIGEMINAL NERVE;

EID: 0031951054     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050766     Document Type: Article

References (52)

1. Abe K, Aoki M, Ikeda M, Watanabe M, Hirai S, Itoyama Y (1996) Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn Superoxide dismutase gene mutations. J Neurol Sci 136: 108-16
2. Andersen PM, Nilsson P, Ala-Hurula V, Keranen ML, Tarvainen I, Haltia T, Nilsson L, Binzer M, Forsgren L, and Marklund SL (1995) Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nature Genet 10: 61-6
3. Bergeron C, Muntasser S, Sommerville MJ, Weyer L, Percy ME (1994) Copper/zinc Superoxide dismutase mRNA levels are increased in sporadic amyotrophic lateral sclerosis motor neurons. Brain Res 639: 272-276
4. Bergeron C, Petrunka C, Weyer L (1996) Copper/zinc dismutase expression in the human central nervous system. Am J Pathol 148: 273-279
5. Blaauwgeers, HGT, Dejong JMBV, Verspaget HW, Vandenberg FM, Troost D (1996) Enhanced Superoxide dismutase-2 immunoreactivity of astrocytes and occasional neurons in amyotrophic lateral sclersois. J Neurol Sci 140: 21-29
6. Borchelt D, Lee M, Slunt H, Guarnieri M, Xu ZS, et al. (1994) Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possess significant activity. Proc Natl Acad Sci USA 91: 8292-8296
7. Bowling AC, Schulz JE, Brown RH Jr, Flint Beal M (1993) Superoxide dismutase activity, oxidative damage and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 61: 2322-2325
8. Cerballos-Picot I, Nicole A, Briand P, Grimber G, Delacourte A, Defossez A, Javoy-Agid F, Lafon M, Blouin JL, Sinet PM (1991) Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome. Brain Res 552: 198-214
9. Geremia E, Baratta D, Zarafana S, Giordano R. Pinizzotto MR, LaRosa MG, Garozzo A (1990) Antioxidant enzymatic systems in neuronal and glial cell rich fractions of rat brain during aging. Neurochem Res 15: 719-723
10. Chan PH, Chu L, Chen SF, Carlson EJ, Epstein CJ (1990) Attenuation of glutamate-induced neuronal swelling and toxicity in transgenic mice overexpressing human CuZn-superoxide dismutase. Acta Neurochir 51: 245-247
11. Colton CA, Gilbert DL (1987) Production of Superoxide anions by a CNS macrophage, the microglia. FEBS Letters 223: 284-288
12. Dal Canto MC, Gurney ME (1995) Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 676: 25-10
13. Delacourte A, Defossez A, Cerballos T, Nicole A, Sinet PM (1988) Preferential localization of copper zinc Superoxide dismutase in the vulnerable conical neurons in Alzheimer's disease. Neurosci Lett 92: 247-253
14. Deng H, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung W, Getzoff ED, et al (1993) Amyotrophic lateral sclerosis and structural defects in Cu, Zn Superoxide dismutase. Science 261:1047-1051
15. Garofalo O, Figlewicz DA, Thomas SM, Butler R, Lebuis L, Rouleau G, Meininger V, Leigh PN (1995) Superoxide dismutase activity in lymphoblastoid cells from motor neurone disease/amyotrophic lateral sclerosis (MND/ALS) patients. J Neurol Sci 129:90-2
16. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. (1994) Motor neuron degeneration in mice that express a human CuZn Superoxide dismutase mutation. Science 264:1772-1775
17. Gurney ME, Cutting FB, Zhai P, Andrus PK, Hall ED (1996) Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn Superoxide dismutase. Pathol Biol 44: 51-56
18. Hall ED, Braughler JM (1988) The role of oxygen radical-induced lipid peroxidation in acute central nervous system trauma. In: Halliwell B,(ed) Oxygen radicals and tissue injury, FASEB, Bethesda, Maryland, pp. 92-98
19. Halliwell B (1992) Reactive oxygen species and the central nervous system. J Neurochem 59: 1609-1623
20. Hartmann HA, Evenson MA (1992) Deficiency of copper can cause neuronal degeneration. Med Hypothes 38: 75-85
21. Hartmann HA, McMahon S, Sun DY, Abbs JH, Uemura E (1989) Neuronal RNA in nucleus arnbiguus and nucleus hypoglossus of patients with amyotrophic lateral sclerosis. J Neuropathol Exptl Neurol 48: 669-673
22. Hughes JT (1982) Pathology of amyotrophic lateral sclerosis. In: Rowland LP (ed) Human motor diseases. Raven. New York pp. 61-74
23. Ikeda K, Kinoshita M, Iwasaki Y, Tagaya N, Shiojima T (1995) Lecithinized Superoxide dismutase retards wobbler mouse mo- toneuron disease. Neuromusc Disord 5: 383-390
24. Ikonomidou C, Qin Qin Y, Labruyere J, Olney JW (1996) Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 55: 211-24
25. Kawaguchi T, Noji S, Uda T, Nakashima Y, Takeyasu A, Kawai Y, Takagi H, Tohyama M, Taniguchi N (1989) A monoclonal antibody against COOH-terminal peptide of human liver manganese Superoxide dismutase. J Biol Chem 264: 5762-5767
26. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J (1993) NMDA-dependent Superoxide production and neurotoxicity. Nature 364: 535-7
27. Lanius RA, Krieger C, Wagey R, Shaw CA (1993) Increased [35S]glutathione binding sites in spinal cords from patients with sporadic amyotrophic lateral sclerosis. Neurosci Lett 163:89-92
28. Liu D, Yang R, Yan X, McAdoo DJ (1994) Hydroxyl radicals generated in vivo kill neurons in the rat spinal cord: Electrophysiological, histological and neurochemical results. J Neurochem 62: 37-44
29. Malamud N (1968) Neuromuscular Diseases. In: Minckler J (ed) Pathology of the nervous system. Macraw-Hill, New York pp. 712-725KD
30. Mann DM, Yates PO (1974) Motor neuron disease: The nature of the pathogenic mechanism. J Neurol Neurosurs Psychiatry 37:1036-1046
31. Matsuyama T, Michishita H, Nakamura H, Tsuchiyama M, Shimizu S, Watanabe K, Sugita M (1993) Induction of copper-zinc Superoxide dismutase in gerbil hippocampus after ischemia. J Cereb Blood Flow Metab 13:135-144
32. McCord JM, Fridovich I (1969) Superoxide Dismutase. J Biol Chem 244: 6049-6055
33. McNamara JO, Fridovich I (1993) Did radicals strike Lou Gehrig? Nature, 362: 20-21
34. Mitsumoto H, Hanson MR, Chad DA (1988) Amyotrophic lateral sclerosis. Arch Neurol 45: 189-202
35. Olszewski J, Baxter D (1954) Cytoarchitecture of the human brain sterm. S Karger, Basel
36. Pappola NA, Omar RA, Kim KS, Robakis NK (1992) Immunohistochemical evidence of antioxidant stress in Alzheimer's disease. Am J Pathol 140: 621-628
37. Pardo CA, Xu Z, Borchelt DR, Price DL, Sisodia S, Cleveland DW (1995) Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci USA 92: 954-958
38. Przedborski S, Donaldson DM, Murphy PL, Hirsch O, Lange D, Naini AB, McKenna-Yasek D, Brown RH Jr. (1996) Blood Superoxide dismutase, catalase and glutathione peroxidase activities in familial and sporadic amyotrophic lateral sclerosis. Neurodegeneration 5: 57-64
39. Robberecht W, Sapp P, Viaene M, Rosen D, McKenna-Yasek D, Haines J, Horvitz R, Theys P, Brown R (1994) Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 62: 384-387
40. Rosen DR, Siddique T, Patterson D, Vanden Bergh R, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown Jr RH (1993) Mutations in Cu/Zn Superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62
41. Saggu H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, Marsden CD (1989) A selective increase in paniculate superoxide dismutase activity in Parkinsonian substantia nigra. J Neurochem 53: 692-697
42. Shaw IC, Fitzmaurice PS, Mitchell JD, Lynch PG (1995) Studies on cellular free radical protection mechanisms in the anterior horn from patients with amyotrophic lateral sclerosis. Neurodegeneration 4: 391-396
43. Shibata N, Hirano A, Kobayashi M, Sasaki S, Kato T, Matsumoto S, Shiozawa Z, Komori A, Ikemoto A, Umahara T, et al. (1994) Cu/Zn Superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis. Neurosci Lett 1994 179: 149-52
44. Siesjo BK, Agardh CD, Bengtsson F (1989) Free Radicals and Brain Damage. Cerebrovasc Brain Metab Rev 1: 165-211
45. Smith RA, Baus FM, Ott KH, Elsberry DD, Sherman MR, Saifer MG (1995) Pharmacokinetics and tolerability of ventricularly administered Superoxide dismutase in monkeys and preliminary clinical observations in familial ALS. J Neurol Sci 129: 13-8
46. Sutherland G, Bose R, Louw D, Pinsky C (1991) Global elevation of brain Superoxide dismutase activity following forebrain ischemia in rat. Neuroscience Letters 128: 169-172
47. Uchino M, Ando Y, Tanaka Y, Nakamura T, Uyama E, Mita S, Murakami T, Ando M (1994) Decrease in CuZn- and Mn-superoxide dismutase activities in brain and spinal cord of patients with amyotrophic lateral sclerosis. J Neurol Sci 127: 61-67
48. Uemura E, Hartmann HA (1978) Age-related changes in RNA content and volume of the human hypoglossal neuron. Brain Res Bull 3: 207-211
49. Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe J, Lee MK, Valentine JS, Bredesen DE (1996) Altered reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis. Science 271: 515-518
50. Yim MB, Rang JH, Yim HS, Kwak HS, Chock PB, Stadtman ER (1996) A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc Nat Acad Sci USA 93: 5709-5714
51. 2 toxcicity. J Appl Physiol 57: 1674-1681
52. Brooks BR (1994) E1 Escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 124 [Suppl]:96-107